Our goal is to make transformative discoveries that will provide important new insights into physiological processes, particularly those that maintain genome and cellular integrity. Where possible, we will also explore how such insights can be translated towards better understanding, diagnosing and/or treating human disease, especially cancer.
We employ a diversity of advanced techniques in our studies, and have a strong track record of using them in innovative new ways as well as in developing and applying new experimental approaches, often in collaboration with other scientists. By providing an interactive, cooperative and stimulating research environment that nurtures independent thinking, our group serves as an excellent platform for personal and professional development, with many of our past trainees having already gone on to have successful careers in academia, industry and other vocations.
STEVE JACKSON'S GROUP CURRENTLY COMPRISES EIGHT POST-DOCS including a bioinformatician, SEven PHD STUDENTS, A LAB MANAGER, FIVE RESEARCH ASSISTANTs including a bioinformatician, AN INFORMATION SPECIALIST, AND A SECRETARY.
The lab belongs to the Cancer Research UK-funded part of the Wellcome Trust/Cancer Research UK Gurdon Institute along with groups led by Tony Kouzarides, Eric Miska, and Phil Zegerman who work on various aspects of molecular cell biology related to cancer, the cell cycle, oncogenes and DNA repair. Our group is part of the Institute building situated in the heart of Cambridge, a short walk from the historic colleges of Cambridge University and adjacent to many of the University's science departments.
In addition, a number post-docs and students in the lab have been awarded personal fellowships. The lab is currently full, however, Steve will always consider informal applications from suitably qualified PhD students and post-doctoral fellows. If you are interested in coming to work in the lab please contact us.
If you have a general inquiry or require reagents from us, please complete the form on our contact page.